Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report

Xianmin Zhu,1 Shuang Dong,1 Jing Tang,1 Rong Xie,1 Huijing Wu,1 Jun Guan,2 Sheng Hu1 1Department of Medical Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Department of Hematology, Wuhan NO.1 Hospital, Wuhan...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zhu X, Dong S, Tang J, Xie R, Wu H, Guan J, Hu S
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2024-06-01
Col·lecció:	Journal of Hepatocellular Carcinoma
Matèries:	hepatocellular carcinoma complete response immune checkpoint inhibitor tislelizumab chemotherapy failure metastasis
Accés en línia:	https://www.dovepress.com/prolonged-complete-remission-using-tislelizumab-for-hepatocellular-car-peer-reviewed-fulltext-article-JHC
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!